Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
Tobramycin 40 mg/ml Solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. Clear colourless solution. |
Each ml of solution for injection contains 40 mg tobramycin.
Each 1 ml vial contains 40 mg of tobramycin.
Each 2 ml vial contains 80 mg of tobramycin.
Each 6 ml vial contains 240 mg of tobramycin.
Excipient(s) with known effect:
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Tobramycin |
Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. |
| List of Excipients |
|---|
|
Sodium metabisulphite |
40 mg/1 ml and 80 mg/2 ml presentation – clear Type I glass vials with elastomeric stoppers in packs of 5 vials.
240 mg/6 ml presentation – clear Type I glass vials with elastomeric stoppers in packs of 1 or 5 vials.
Not all presentations above may be marketed.
Hospira UK Limited, Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, UK
PL 04515/0066
Date of first authorisation: 22/09/1993
Date of latest renewal: 26/02/2009
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
